CI241227P285000
- 7.00
- -3.05-30.35%
Cigna Group Newsroom
Dongbei Securities: Initiates a "Buy" rating on EDIANYUN as signs of a turnaround in IT service performance are starting to emerge.
Northeast Securities released a research report stating that it has initiated coverage on EDIANYUN (02416) with a "Buy" rating. The firm expects that during this economic cycle, an increasing number of small and medium-sized enterprises will enhance their risk resistance by leasing equipment from office equipment suppliers. The company's performance is expected to continue growing, with projected revenues of 1.336/1.604/2.13 billion yuan and net income of 0.047/0.148/0.267 billion yuan for 2024-2026. The main points of the report are as follows: the company provides on-demand office IT integrated solutions and other services through cloud-based office.
P/E Ratio Insights for Cigna
Mizuho has lowered The Cigna Group's Target Price to $360.
On December 24, Gelonghui reported that Mizuho has lowered The Cigna Group's Target Price from $385 to $360, maintaining an "Outperform" rating. (Gelonghui)
Buckle up! Goldman Sachs: Market optimism is nearing its peak, Bullish on two defensive Sectors.
①Goldman Sachs advises investors to take more "defensive measures" as Wall Street's optimism about the USA economy and stock market approaches historical highs. ②Goldman Sachs' model is bullish on the performance of defensive stocks such as utilities and Medical Care.
Mizuho Securities Maintains Cigna Group(CI.US) With Buy Rating, Announces Target Price $360
Looking Into Cigna's Recent Short Interest
Mizuho Adjusts Price Target on Cigna Group to $360 From $385, Keeps Outperform Rating
How to find the "alpha" market in U.S. stocks next year? Goldman Sachs provides an investment guide.
Zhihui Finance has learned that Goldman Sachs analysts said in a report that over the next six months, the materials, Software, and services industries in the USA are most likely to outperform the Large Cap. Goldman Sachs strategist David Kostin stated in a report on December 20 that they introduced a model for USA Stocks to select industries expected to exceed the benchmark Index by 5 percentage points or more, "to identify 'high conviction' views with significant Alpha potential." He noted, "Our model incorporates macro, fundamental, and valuation data as independent variables. We run probability models separately for each Industry, only including
Materials, Software Stocks Are Best Poised for H1 Outperformance: Goldman Sachs
The Returns At Cigna Group (NYSE:CI) Aren't Growing
Express News | Limin Group: Signed a Global Strategy cooperation agreement to expand the small peptide biopesticide.
U.S. Healthcare Spending Climbs 7.5% in 2023
Your Healthcare Costs Are Soaring! US Spending Reached $5 Trillion In 2023 With Major Increase in Obesity and Diabetes Drugs, Hospital Services
Cigna (CI) Soars 6.3%: Is Further Upside Left in the Stock?
Shares of Pharmacy Benefit Managers and Insurance Stocks Are Trading Higher. The Sector May Be Rebounding After Falling on Recent Comments From President-elect Trump Criticizing the Space.
10 Health Care Stocks With Whale Alerts In Today's Session
Spending Bill Targets Pharmacy Benefit Managers, But Shares Rise Anyhow -- Barrons.com
Benzinga Market Summary: Dow Rises Following Recent Weakness, Pharmacy Benefit Managers Rebound, Fed Rate Decision To Be Announced At 2:00 P.m.
If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today
Express News | Cigna Group Shares Hit Session Low With Volume Pickup, Last Down 3% at $273.22